- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Bladder Cancer in United Kingdom
Total 24587 results
-
National Cancer Institute (NCI)Active, not recruitingBladder Urothelial Carcinoma | Stage IIIA Bladder Cancer AJCC v8 | Muscle Invasive Bladder Carcinoma | Stage II Bladder Cancer AJCC v8United States
-
PfizerWithdrawnBladder CancerPoland, United States
-
Vaxiion TherapeuticsCompletedUrothelial Carcinoma of the Urinary BladderUnited States
-
AllerganCompletedOveractive BladderPoland, United Kingdom, Belgium, Russian Federation, Czech Republic, Germany, United States
-
Merck Sharp & Dohme LLCRecruitingHigh-risk Non-muscle Invasive Bladder CancerCanada, Belgium, United States, Australia, Austria, France, Germany, Greece, Hungary, Italy, Japan, Korea, Republic of, Malaysia, Netherlands, Peru, Poland, Portugal, Spain, Switzerland, Turkey, United Kingdom, China, Brazil, Colombia, ... and more
-
National Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol Specific | Recurrent Melanoma | Recurrent Bladder Cancer | Stage IV Bladder Cancer | Male Breast Cancer | Stage IV Breast Cancer | Stage IV Melanoma | Recurrent Breast Cancer | Stage III MelanomaUnited States
-
Cancer Research UKHummingbird BioscienceRecruitingMelanoma | Cervical Cancer | Gastric Cancer | Pancreatic Cancer | Ovarian Cancer | Hepatocellular Carcinoma (HCC) | Bladder Cancer | Triple Negative Breast Cancer | Endometrial Cancer | Castration-resistant Prostate Cancer | Non-small Cell Lung Cancer (NSCLC) | Oesophageal Cancer | RAS Wild Type Colorectal Cancer | Squamous Cell Cancer of the Head and NeckUnited Kingdom
-
University of OxfordKing's College London; Bayer; Boston Children's Hospital; Queen Mary University... and other collaboratorsCompletedChronic Pain | Endometriosis | Bladder Pain SyndromeUnited Kingdom, Portugal
-
NYU Langone HealthMerck Sharp & Dohme LLCActive, not recruitingMuscle-invasive Urothelial Cancer of the BladderUnited States
-
M.D. Anderson Cancer CenterFlight Attendant Medical Research InstituteCompleted
-
David LatiniCompleted
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)Recruiting
-
Hoffmann-La RocheTerminated
-
Hoffmann-La RocheRecruitingMuscle-invasive Bladder CancerBelgium, Korea, Republic of, Japan, Brazil, China, United States, Singapore, France, United Kingdom, Canada, Greece, Italy, Spain, Turkey, Russian Federation, Ukraine, Israel, Czechia, Colombia, Hong Kong, Argentina, Germany, Ireland, Polan... and more
-
Seagen Inc.GenmabCompletedBladder Cancer | Cervix Cancer | Ovary Cancer | Esophagus Cancer | Endometrium Cancer | Prostate Cancer (CRPC) | Lung Cancer (NSCLC)United States, United Kingdom, Belgium, Hungary, Denmark
-
Memorial Sloan Kettering Cancer CenterFox Chase Cancer Center; University of ChicagoRecruitingBladder Cancer | Urothelial Cancer | Ureter Cancer | Renal Pelvis CancerUnited States
-
AllerganCompletedOveractive Bladder | Urinary IncontinencePoland, Germany, United States, Canada, United Kingdom, Belgium
-
H. Lee Moffitt Cancer Center and Research InstituteCompletedCarcinoma, Transitional Cell | Bladder Cancer | Urethra Cancer | Ureter Cancer | Renal Pelvis CancerUnited States
-
CG Oncology, Inc.WithdrawnBladder Cancer | High Grade | Non Muscle InvasiveUnited States
-
AstraZenecaRecruitingMuscle Invasive Bladder CancerNetherlands, United Kingdom, Korea, Republic of, Canada, Germany, Italy, Poland, Spain, Turkey, Vietnam, Argentina, Japan, France, Brazil, Taiwan, United States, Israel, Austria, Chile, Colombia, Greece, Hong Kong, Mexico, Portugal, Russian... and more
-
Memorial Sloan Kettering Cancer CenterCompletedBladder Cancer | High Risk SuperficialUnited States
-
National Cancer Institute (NCI)Recruiting
-
M.D. Anderson Cancer CenterSuspendedBladder Cancer | BladderUnited States
-
Lahey ClinicActive, not recruiting
-
University of WashingtonPatient-Centered Outcomes Research InstituteActive, not recruitingBladder Cancer | Non-muscle Invasive Bladder Cancer | Cancer of the Bladder, RecurrentUnited States
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdActive, not recruitingUrinary Bladder Neoplasms | Muscle-Invasive Bladder CancerRussian Federation, United States, Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, Colombia, Finland, France, Germany, Greece, Israel, Italy, Japan, Korea, Republic of, Mexico, Netherlands, New Zealand, Norway, Portugal, Roman... and more
-
Memorial Sloan Kettering Cancer CenterMerck Sharp & Dohme LLCRecruiting
-
Medical University of South CarolinaTerminatedBladder CancerUnited States
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI)Completed
-
Memorial Sloan Kettering Cancer CenterRockefeller University; Pin Down Bladder Cancer Research FoundationRecruitingNon-muscle Invasive Bladder CancerUnited States
-
Baylor College of MedicineM.D. Anderson Cancer Center; University of Rochester; Laval UniversityCompleted
-
Celldex TherapeuticsTerminated
-
Processa PharmaceuticalsCompletedSolid Tumor | Metastatic Bladder CancerUnited States
-
Jonsson Comprehensive Cancer CenterMerck Sharp & Dohme LLCCompletedUrothelial Carcinoma | Castration-Resistant Prostate Carcinoma | Stage IV Prostate Cancer AJCC v8 | Metastatic Bladder Urothelial Carcinoma | Metastatic Urethral Urothelial Carcinoma | Stage III Bladder Cancer AJCC v8 | Stage III Urethral Cancer AJCC v8 | Stage IV Bladder Cancer AJCC v8 | Stage IV Urethral... and other conditionsUnited States
-
Endo PharmaceuticalsTerminated
-
H. Lee Moffitt Cancer Center and Research InstituteCG Oncology, Inc.; Richard M. Shulze Family FoundationActive, not recruitingBladder Cancer | Muscle-Invasive Bladder CarcinomaUnited States
-
Mark DewhirstCompletedTransitional Cell Carcinoma of Bladder | Superficial Bladder CancerUnited States
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI)CompletedBladder CancerUnited States, Canada
-
Astellas Pharma IncCompletedOveractive Bladder | Neurogenic Detrusor OveractivityBelgium, Canada, Denmark, Netherlands, Poland, Turkey, United Kingdom
-
UroGen Pharma Ltd.CompletedBladder Cancer | Urothelial Carcinoma Bladder | Urothelial CarcinomaUnited States
-
Spectrum Pharmaceuticals, IncAllerganTerminatedBladder CancerUnited States, Poland, Czechia, Slovakia
-
PhotocureKARL STORZ Endoscopy-America, Inc.Completed
-
PhotocureCatalyst Pharmaceutical ResearchRecruiting
-
The Christie NHS Foundation TrustUniversity of Liverpool; University of Manchester; Wythenshawe HospitalActive, not recruitingUterine Cervical Neoplasms | Urinary Bladder Neoplasms | Endometrial NeoplasmsUnited Kingdom
-
Northwell HealthFox Chase Cancer CenterRecruitingPatient Engagement | Bladder Cancer | Patient Empowerment | Ileal ConduitUnited States
-
Hoffmann-La RocheCompletedBladder CancerUnited States, France, Belgium, Korea, Republic of, United Kingdom, Czechia, Austria, Canada, Denmark, Greece, Italy, Netherlands, Portugal, Slovenia, Spain, Sweden, Turkey, Poland, Hungary, Switzerland, Japan, Taiwan, Australia, Norway, Germa... and more
-
The Cleveland ClinicCompletedProphylactic Urethral Stenting With Memokath After Prostate Implantation for Prostate AdenocarcinomaProstate Cancer | Post-Brachytherapy Bladder Outlet ObstructionUnited States
-
Royal Marsden NHS Foundation TrustRecruitingBiliary Tract Neoplasms | Neoplasm, Bladder | Neoplasm of Lung | Neoplasms Pancreatic | Neoplasm, Colorectal | Gastro Intestinal Stromal TumourUnited Kingdom
-
CG Oncology, Inc.CompletedSafety and Efficacy of CG0070 Oncolytic Virus Regimen for High Grade NMIBC After BCG Failure (BOND2)Bladder CancerUnited States
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedBladder Cancer | Urethral CancerUnited States